AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 131 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $1,685,000 | -64.0% | 130,000 | -64.0% | 1.05% | -72.5% |
Q1 2021 | $4,685,000 | -33.4% | 360,834 | -29.1% | 3.84% | +18.0% |
Q4 2020 | $7,036,000 | -19.7% | 508,715 | -14.5% | 3.25% | -22.0% |
Q3 2020 | $8,764,000 | +486.2% | 595,000 | +546.7% | 4.17% | +549.2% |
Q2 2020 | $1,495,000 | – | 92,000 | – | 0.64% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |